U.S. Markets closed

Alexza Pharmaceuticals' Adasuve approved by FDA

Alexza Pharmaceuticals announced that the FDA approved Adasuve Inhalation Powder 10 mg for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults. Adasuve combines Alexza's proprietary Staccato delivery system with the antipsychotic drug, loxapine.